Biolife Solutions (BLFS) Enterprise Value (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Enterprise Value data on file, last reported at -$81.0 million in Q1 2026.

• On a quarterly basis, Enterprise Value rose 8.56% year-over-year to -$81.0 million in Q1 2026; TTM through Mar 2026 was -$81.0 million, a 8.56% increase from a year earlier, with the FY2025 full-year figure at -$88.9 million, up 11.72% from the prior year.
• Enterprise Value for Q1 2026 stood at -$81.0 million, up from -$88.9 million in the prior quarter.
• Over the last five years, Enterprise Value for BLFS reached as high as -$19.5 million in Q4 2022 and fell as low as -$100.7 million in Q4 2024.
• Historically, Enterprise Value has averaged -$57.9 million across 5 years, with a median of -$54.9 million in 2023.
• Across the five-year window, Enterprise Value jumped 72.13% in 2022 and slumped 270.9% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$19.5 million in 2022, then tumbled by 126.9% to -$44.2 million in 2023, then tumbled by 127.99% to -$100.7 million in 2024, then rose by 11.72% to -$88.9 million in 2025, then grew by 8.92% to -$81.0 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$81.0 million in Q1 2026, -$88.9 million in Q4 2025, and -$79.0 million in Q3 2025.